FONDAZIONE RI.MED

Their core work

Fondazione Ri.MED is a biomedical research institute based in Palermo, Sicily, focused on engineering biological tissues and devices that replicate the mechanical and structural properties of human cardiac valves. Their core work combines biomaterials science, biomechanics, and tissue engineering to design valve replacements that behave more like native tissue than current synthetic or biological prosthetics. In the BIOMITRAL project — an ERC Consolidator Grant they coordinate — they are developing a bioinspired mitral valve that mimics the natural architecture of fibrous heart tissue to achieve superior in vivo performance. They also contribute to multiscale computational modeling of musculoskeletal disease, as demonstrated by their participation in the OACTIVE osteoarthritis prevention project.

What they specialise in

How they've shifted over time

In their first H2020 project (OACTIVE, 2017-2021), Ri.MED participated as a partner in a computational and clinical osteoarthritis prevention effort — a broad health engineering context with no published keywords associated with their specific contribution. From 2021 onward, their focus sharpened dramatically toward cardiac tissue engineering, specifically the mitral valve, with an ERC Consolidator Grant they coordinate themselves. The shift moves from musculoskeletal modeling as a participant to bioinspired cardiac device development as a principal investigator — a meaningful increase in both specificity and scientific leadership.

Ri.MED is moving toward becoming a specialist in bioinspired cardiac implant engineering, with their ERC grant signaling recognized research leadership in this niche — making them a strong partner for consortia targeting cardiovascular device innovation, regenerative medicine, or advanced biomaterials for implants.

How they like to work

Ri.MED has taken both roles in EU consortia — partner in a large multidisciplinary health project and independent coordinator of a focused ERC grant. Their coordinator experience on BIOMITRAL suggests capacity for scientific leadership and project management, not just execution. With 15 distinct partners across 7 countries from only 2 projects, they appear to engage in moderately large, diverse consortia rather than narrow bilateral collaborations.

Ri.MED has built connections with 15 unique partners across 7 countries through just two projects, suggesting active and broad network engagement relative to their project volume. Their collaboration footprint spans multiple European nations, consistent with their participation in both a large RIA consortium and an ERC grant with international collaborators.

What sets them apart

Ri.MED holds a rare combination for a Southern Italian research center: an ERC Consolidator Grant in cardiac tissue engineering, which signals peer-reviewed scientific excellence at the European frontier level. Their bioinspired approach to valve design — mimicking native fibrous architecture rather than substituting with generic synthetic materials — positions them in a specialized niche between materials science, biomechanics, and cardiovascular medicine. For consortium builders, they offer both scientific credibility and the ability to lead, which is uncommon for organizations with a small project portfolio.

Highlights from their portfolio

• BIOMITRAL
  An ERC Consolidator Grant coordinated by Ri.MED — the most prestigious individual research grant in Europe — focused on engineering a bioinspired mitral valve, representing both their highest funding award and their clearest statement of scientific identity.
• OACTIVE
  Their entry into EU-funded research through a multi-partner RIA on osteoarthritis prevention, demonstrating early capability to contribute to large-scale computational health modeling projects.